&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-04-28, 21:00

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-03-05, 21:00

Pow.Bio Unveils State-of-the-Art Facility in Alameda, Expanding Biomanufacturing Capabilities to Support Demand for Continuous Fermentation
Kia Stones

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-07, 20:00

Hummingbird Bioscience Licenses Novel Antibodies to Immunome
Bud Eliott

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-12-09, 19:03

AiViva Biopharma Receives FDA Clearance to Administer AIV001 in Facial Skin by Intradermal Injection for Nonmelanoma Skin Cancer

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-07, 20:00

Winners in First Annual Stevie® Awards for Technology Excellence Announced
Jannie Boothby

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-03, 15:30

Olon Group Announces the Acquisition of GTP Bioways Group
Monique Kunkel

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-20, 07:00

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2250a8861042&size=3[/img]

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-13, 16:30

Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-12-11, 20:00

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2023-10-31, 18:00

Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules
Britney MacDevitt

Popular Posts